Evidence map›Paper›PMID 29258958›Full record

ArticleJournal of pediatric and adolescent gynecology2018

Pubertal Progression in Female Adolescents with Progeria.

Maya Mundkur Greer, Monica E Kleinman, Leslie B Gordon, Joe Massaro, Ralph B D'Agostino, Kristin Baltrusaitis, Mark W Kieran, Catherine M Gordon

Open access · greenAbstract read
In one paragraph

Article in Journal of pediatric and adolescent gynecology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Lonafarnib clinical trials demonstrate uncoupling of the muscle-bone unit in Hutchinson-Gilford Progeria Syndrome.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Maya Mundkur GreerDepartment of Anesthesia, Boston Children's Hospital, Boston, Massachusetts.
Monica E KleinmanDepartment of Anesthesia, Boston Children's Hospital, Boston, Massachusetts.
Leslie B GordonDepartment of Anesthesia, Boston Children's Hospital, Boston, Massachusetts; Department of Pediatrics, Hasbro Children's Hospital and Warren Alpert Medical School of Brown University, Providence, Rhode Island.
Joe MassaroDepartment of Mathematics and Statistics, Boston University, Harvard Clinical Research Institute, Boston, Massachusetts.
Ralph B D'AgostinoDepartment of Mathematics and Statistics, Boston University, Harvard Clinical Research Institute, Boston, Massachusetts.
Kristin BaltrusaitisDepartment of Mathematics and Statistics, Boston University, Harvard Clinical Research Institute, Boston, Massachusetts.
Mark W KieranDivision of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
Catherine M GordonDepartment of Pediatrics, Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, Ohio. Electronic address: catherine.gordon@cchmc.org.
Baim Institute for Clinical Research · USBoston Children's Hospital · USBoston University · USCincinnati Children's Hospital Medical Center · USHarvard University · USHasbro Children's Hospital · US

Funding

Harvard Clinical and Translational Science CenterUL1TR001102 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2013 to 2017
$106.2M
HARVARD CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1)UL1RR025758 · NCRR · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2008 to 2011
$91.4M
WIRELESS CAPSULE ENDOSCOPY TO EVALUATE THE SMALL INTESTINE M01RR002172 · NCRR · CHILDREN'S HOSPITAL BOSTON · PI MANDELL, JAMES WILLIAM · 1985 to 2008
$16.0M
Phase II Trial of Lonafarnib, Pravastatin and Zoledronic Acid in ProgeriaRC2HL101631 · NHLBI · DANA-FARBER CANCER INST · PI KIERAN, MARK WILLIAM · 2009 to 2010
$3.3M
NCATS NIH HHS UL1 TR001102NCRR NIH HHS M01 RR002172NCRR NIH HHS UL1 RR025758NHLBI NIH HHS RC2 HL101631
6 · The paper itself

Abstract

STUDY

objectiveThis study identified the prevalence of menarche and coincident sexual characteristics in female adolescents with Hutchinson-Gilford Progeria Syndrome (HGPS).

designData were examined to determine the prevalence of menarche in female adolescents older than 12 years; all were participants in clinical trials between 2007 and 2016.

settingPediatric hospital in Boston, Massachusetts.

participantsFifteen female adolescents, median age 15 (range, 12.0-20.3) years with a confirmed diagnosis of HGPS. INTERVENTIONS AND

main outcome measuresReport of menarche, anthropometric and serum hormonal measures, Tanner pubertal staging, and body composition using dual-energy x-ray absorptiometry.

resultsNine of 15 (60%) participants reported spontaneous menarche at a median age of 14.4 years (range, 12.0-16.5 years). In those experiencing menarche vs not, median age was older (16.5 vs 13.6 years; P = .02), whereas body mass index did not differ (10.5 vs 10.4; P = .53) nor percentage body fat (19.4% vs. 19.3%; P = .98) or serum leptin levels (0.40 vs 0.40 ng/mL; P = .23). Among those who achieved menarche, 2 of 9 (22%) had Tanner II breast development and 2 of 9 (22%) exhibited Tanner II Pubic hair, all reflecting minimal pubertal development. Only early signs of puberty were similarly seen in the non-menstruating group, including 1 of 6 (17%) with Tanner II breasts and 2 of 6 (33%) with Tanner II pubic hair, and Tanner staging did not differ between those who reported menarche vs those who did not (each P = 1.0). None of the participants achieved Tanner IV or V thelarche over the course of the study.

conclusionMenarche was achieved in more than half of adolescent girls with HGPS, in the setting of little to no physical signs of pubertal development and minimal body fat.

Indexed as

Absorptiometry, PhotonAdolescentAdultAnthropometryBody CompositionBostonChildFemaleHumansLeptinProgeriaPubertySexual MaturationYoung AdultLeptinAtherosclerosisLaminMenarcheProgeriaPuberty

Identifiers

PMID29258958
PMCPMC6671321
OpenAlexW2774022632

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.